Haiping Dai

23PUBLICATIONS
50CO-AUTHORS
Haematological tumoursApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Predictive and prognostic markersMedicine, nursing and health curriculum and pedagogyAutomotive safety engineering
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (23)

|Jul 14, 2026
IKZF1N159S is associated with adverse outcomes in patients with myelodysplastic neoplasms.

|Feb 04, 2026
Coexistence of BCR::ABL1 with IKZF1::ETV6 fusion in an adult patient with acute B-lymphoblastic leukemia.

Kai-Wen Tan, Yi Xu, Yuan-Hong Huang

|Jan 28, 2026
Treatment outcome and efficacy of desensitization strategies for immunized-PTR in hematological malignancies before hematopoietic stem cell transplantation.

Yizhou Pan, Yuanling Zuo, Qingya Cui

|Oct 28, 2025
IL-6 knockdown anti-CD19 CAR-T cells (ssCART-19) for patients with relapsed or refractory acute lymphoblastic leukemia: phase 1 trial.

Sheng-Li Xue, Mei-Jing Liu, Chong-Sheng Qian

|Sep 16, 2025
Developing a Framework of Entrustable Professional Activities for Residency Training in Hematology.

Hong Tian, Lan Xu, Jing Xi

|Jul 02, 2025
Adult AML with NUP98 rearrangements should be stratified into adverse-risk group.

Wusixian Huang, Man Wang, Jundan Xie

Pageof 4

Frequent Collaborators

13 joint publications

Shengli Xue

4 joint publications

Depei Wu

3 joint publications

Xiaowen Tang

3 joint publications

Shuai-Shuai Ge